Italy To Relax Biosimilar Switching Rules In Cost-Savings Effort

 
• By Ian Schofield
  
Reducing costs
Italy is encouraging biosimilar use to help reduce spending on biologic drugs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics